AlzGenPred - 基于CatBoost的基因分类器,用于使用高通量测序数据预测阿尔茨海默病.
Rohit Shukla1,2, Tiratha Raj Singh3,4
1Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology (JUIT), Waknaghat, Solan, 173234, H.P., India.
Scientific reports
|December 5, 2024
概括
AlzGenPred使用机器学习识别了阿尔茨海默病 (AD) 基因. 基于网络的功能实现了高精度,为AD生物标志物发现提供了可靠的工具.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响记忆力.
- 存在大量与AD相关的基因组数据,但基因参与需要进一步阐明.
- 识别AD相关基因对于理解疾病机制和开发治疗方法至关重要.
研究的目的:
- 开发一种基于机器学习的工具AlzGenPred,用于准确识别与阿尔茨海默病相关的基因.
- 评估不同特征类型 (基于序列或基于网络) 在预测AD相关基因中的有效性.
- 为加速AD生物标志物发现提供一个用户友好的平台.
主要方法:
- 从八个序列编码方案中生成了13504个特征,并评估了16个机器学习算法.
- 基于序列和基于网络的特征用于AD基因识别的性能比较.
- 使用基于网络的功能与CatBoost机器学习模型开发AlzGenPred.
主要成果:
- 基于网络的特征在区分AD相关基因方面明显优于基于序列的特征.
- 仅靠基于序列的特征无法实现高分类准确度.
- AlzGenPred实现了96.55%的准确性和98.99%的AUROC,在AlzGene数据集和转录组学数据上得到了验证.
结论:
- AlzGenPred是一种高度准确和可靠的工具,用于识别潜在的阿尔茨海默病生物标志物.
- 这项研究强调了基于网络的特征对AD基因预测的优越性.
- AlzGenPred促进了加速生物标志物发现,并增强了对阿尔茨海默病的理解.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...